Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irina Klaman

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Molecular Cancer|December 18, 2007
Genome-wide expression patterns of invasion front, inner tumor mass and surrounding normal epithelium of colorectal tumorsEike Staub, Joern Groene, Maya Heinze, et al.
BMC Cancer|December 15, 2012
Overexpression of SERBP1 (Plasminogen activator inhibitor 1 RNA binding protein) in human breast cancer is correlated with favourable prognosisNuran Bektas Serce, Andreas Boesl, Irina Klaman, et al.
International Journal of Cancer|May 25, 2006
Transcriptional census of 36 microdissected colorectal cancers yields a gene signature to distinguish UICC II and IIIJoern Groene, Ulrich Mansmann, Reinhard Meister, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2006
Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin alpha2 as a potential novel prognostic marker in breast cancerEdgar Dahl, Glen Kristiansen, Kathrin Gottlob, et al.
International Journal of Oncology|August 4, 2004
Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumorsEva Klopocki, Glen Kristiansen, Peter J Wild, et al.
Science Translational Medicine|June 17, 2021
Macrophage depletion induces edema through release of matrix-degrading proteases and proteoglycan depositionStefan Bissinger, Carina Hage, Vinona Wagner, et al.
Science Translational Medicine|April 13, 2018
T cell-induced CSF1 promotes melanoma resistance to PD1 blockadeNatalie J Neubert, Martina Schmittnaegel, Natacha Bordry, et al.
European Journal of Cancer (Oxford, England : 1990)|November 8, 2020
Long-term clinical activity, safety and patient-reported quality of life for emactuzumab-treated patients with diffuse-type tenosynovial giant-cell tumourPhilippe A Cassier, Antoine Italiano, Carlos Gomez-Roca, et al.
Journal for Immunotherapy of Cancer|October 24, 2020
Phase Ib study of anti-CSF-1R antibody emactuzumab in combination with CD40 agonist selicrelumab in advanced solid tumor patientsJean-Pascal Machiels, Carlos Gomez-Roca, Jean-Marie Michot, et al.
The Journal of Pathology|December 9, 2004
Systematic identification and molecular characterization of genes differentially expressed in breast and ovarian cancerEdgar Dahl, Ariane Sadr-Nabavi, Eva Klopocki, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Molecular Cancer|December 18, 2007
Genome-wide expression patterns of invasion front, inner tumor mass and surrounding normal epithelium of colorectal tumorsEike Staub, Joern Groene, Maya Heinze, et al.
BMC Cancer|December 15, 2012
Overexpression of SERBP1 (Plasminogen activator inhibitor 1 RNA binding protein) in human breast cancer is correlated with favourable prognosisNuran Bektas Serce, Andreas Boesl, Irina Klaman, et al.
International Journal of Cancer|May 25, 2006
Transcriptional census of 36 microdissected colorectal cancers yields a gene signature to distinguish UICC II and IIIJoern Groene, Ulrich Mansmann, Reinhard Meister, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2006
Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin alpha2 as a potential novel prognostic marker in breast cancerEdgar Dahl, Glen Kristiansen, Kathrin Gottlob, et al.
International Journal of Oncology|August 4, 2004
Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumorsEva Klopocki, Glen Kristiansen, Peter J Wild, et al.
Science Translational Medicine|June 17, 2021
Macrophage depletion induces edema through release of matrix-degrading proteases and proteoglycan depositionStefan Bissinger, Carina Hage, Vinona Wagner, et al.
Science Translational Medicine|April 13, 2018
T cell-induced CSF1 promotes melanoma resistance to PD1 blockadeNatalie J Neubert, Martina Schmittnaegel, Natacha Bordry, et al.
European Journal of Cancer (Oxford, England : 1990)|November 8, 2020
Long-term clinical activity, safety and patient-reported quality of life for emactuzumab-treated patients with diffuse-type tenosynovial giant-cell tumourPhilippe A Cassier, Antoine Italiano, Carlos Gomez-Roca, et al.
Journal for Immunotherapy of Cancer|October 24, 2020
Phase Ib study of anti-CSF-1R antibody emactuzumab in combination with CD40 agonist selicrelumab in advanced solid tumor patientsJean-Pascal Machiels, Carlos Gomez-Roca, Jean-Marie Michot, et al.
The Journal of Pathology|December 9, 2004
Systematic identification and molecular characterization of genes differentially expressed in breast and ovarian cancerEdgar Dahl, Ariane Sadr-Nabavi, Eva Klopocki, et al.
Pageof 3